Conference Room

Workshop Room

Conference Room

Regulation, Legislation & Research

Conference Chair

Matt Lawson

Co-Founder

The Canna Consultants

Hosted by:

09:00-09:10

Welcome to the Malta Medical Cannabiz World Summit

Matt Lawson

09:10-09:20

A Maltese vision

The small island nation is intent on taking the medical cannabis industry head on. What steps are being taken to ensure that it’s a success?

Hon. Chris Cardona

09:20-09:30

The European standpoint

Ladies and gentlemen, please give a warm welcome to European parliamentarian, Miriam Dalli, as she elucidates her thoughts on this fast-growing space.

Hon. Miriam Dalli

09:30-10:10

The Future of CBD in Europe

The emergence of CBD is driving product innovation on all fronts. Let’s take a third person view at shifting market regulations on cannabis extracts, and the state of product supply chains at an EU level.

Richard Sharp

Cobidol

Jon Liebling

Henri Sant-Cassia

Stephen Oliver

Dave Charnick

Lizi Jenkins

10:10-10:20

Next steps: research & development for medical cannabis

How has Malta’s recent legal push on the medical cannabis front affected R&D targets within the scientific community?

Hon. Deo Debattista

10:20-10:30

Malta Enterprise on medical cannabis

It’s time for a quickfire overview of Malta Enterprise’s function within the life sciences sector.

Marion Zammit

10:30-10:45

From Tragedy to Triumph

An inspirational story characterised by one mother’s journey to find a cure.

Tracy Ryan

10:45-11:00

The medical cannabis business proposition

What steps does a company need to take to operate successfully in this seed-stage sector?

Yona Levy

Alvit LCS Pharma
11:00-11:10

Bootstrapping the endocannabinoid system

Let’s analyse a compelling argument for boosting the body’s natural endocannabinoids.

 

 

Giuseppe Di Giovanni

11:10-11:20

Patient to advisor

A journey of discovery.

Jade Proudman

11:20-11:40

Pioneering white space for Canna-brands

How do we use data-science to distil irrefutable human insights and forge a brand narrative in a rapidly evolving market?

Anthony Wolch

Beyond Marketing Group
11:40-11:50

Beyond borders: a new frontier for medical cannabis

As the medical cannabis industry expands, the expectation of an international regulatory framework and policy formation grows with it. What would a global approach look like?

Marcus Ramkissoon

11:50-12:00

From principle to practice: a client-centred approach

How can we maximise accurate and efficient clinical research while also enhancing client-side benefits?

Anne Katrin Schlag

12:00-12:10

Challenging the status quo: the case for mass adoption

Accurate data compiled with proprietary patient registry software is set to improve decision making from both a regulatory and practitioner’s perspective. Let’s dive right in.

Prad Sekar

12:10-12:20

Medical Malta: a regulatory update

What can Malta learn from the various regulatory approaches championed by forward-looking nations?

Alexander Pombo

Nerum Pharmaceuticals

Start up pitch

12:30-14:00

Start up pitch

10 medical cannabis start ups with innovative projects will pitch on stage in front of established entrepreneurs and savvy investors. Set your sights on the moon and battle it out in a shark-tank environment with some tough love from a select panel of stern judges.

Monty Munford

Adam Shuster

Michael Patterson

Petar Savic

Supreme Factory

Maya Glogowski

Jason Corbett

Isabel Fox

Investment Opportunities

Conference Chair

Isabel Fox

Co-Founder

The Cannabis Fund

Hosted by:

14:00-14:10

Peering across the investment landscape

What are investors eyeing in this growing sector?

Nick Tulloch

14:10-14:30

Cannabis: From Laboratory to Living Room

It’s time to explore the immense social, medical, and economic impact this budding sector will have on the world at large.

Sumit Mehta

Monica Vialpando

Nicole Fox

14:30-14:40

Establishing your medical cannabis business in Malta

Time to present the nuts and bolts guide to establishing your business in medical Malta.

Christopher Emms

Green Goblin
14:40-14:50

Safe and legal: from disruption to mainstream adoption

What was once a disruptive market is now emerging as an accepted mainstream medical product. Let’s dive into the use-cases.

Vladas Snieckus

14:50-15:00

Subsidising first movers in the medical cannabis industry

What are the challenges faced by companies at each funding stage?

Richard Skaife

Cobichain
15:00-15:10

Guidelines for Medical cannabis investment in North Macedonia

The new legislation and the low cost possibilities of opening a business in cannabis cultivation and oil extraction.

Dejan Gacov

15:10-15:20

Cannabis in the US: an industry overview

Let’s get an overall sense of this growing market, its potential for development and the impact of legislative changes at both a state and federal level.

William J. Pascrell, III

15:20-15:40

Venture capital, fund restrictions and start-ups

Injecting capital into crop cultivation, emerging technology, and medical cannabis services can be cumbersome within a hesitant capital environment. How can start-ups get the funds they need to push onwards?

Isabel Fox

Mark Hamade

Baran Dilaver

Jason Corbett

15:40-15:50

Fertile ground: real estate investment opportunities

How does a prospective entrepreneur plan the acquistion, design and construction of a medical cannabis facility?

Daniel Sax

15:50-16:00

New horizons: pharmaceutical cannabis opportunities

How can cannabis be applied to the pharmaceutical industry?

16:00-16:10

Ancillary Services

What kinds of ancillary businesses are needed to support and grow the medical cannabis sector?

Anuj Desai

16:10-16:20

From farm to pharma: Israel's experience

Clinical trials in medical cannabis have proven to be successful in Israel. How does this compare to the EU?

Golan Bitton

UNIVO
16:20-16:40

Medical Malta: the medical cannabis island

Let’s analyse the plethora of reasons to setup your business in sunny Malta.

Christopher Emms

Green Goblin

Gianluca Caruana Curran

16:40-16:50

Raising Capital for US Cannabis Ventures

How does one raise capital while maintaining compliance with state, federal and FDA regulations?

Dave Rodman

16:50-17:00

Cannabis Investment Through a Stethoscope

Serious investors must look at a diversified portfolio to minimise risk and maximise returns. Let’s take a look at China’s CBD impact on the global market.

Sumit Mehta

17:00-17:10

Canada's pearls and pitfalls

What does the Canadian market look like one year after legalisation? Does this regulatory framework address today’s needs?

Jaspreet Grewal

17:10-17:30

VC's and PE

Venture capitalists and private equity funds are heavily involved in the North American medical cannabis market. How does this compare to Europe?

Monty Munford

Daniel Sax

Isabel Fox

Sumit Mehta

Mikko Puhakka

17:30-17:40

Left behind? The pitfalls of traditional financing models

How is stigma and uncertainty preventing medical cannabis companies from raising capital through banks and lending institutions?

Mark Hamade

17:40-17:50

Market analysis: trends and expectations

Understanding the global impact of evolving medical cannabis markets.

Kris Krane

17:50-18:00

Seeing eye-to-eye: society and investors

As investment firms look for more socially responsible projects to put their money into, how is the medical cannabis industry benefiting?

Christian Clapton

Workshop Room

Emerging Medical Cannabis Markets expand icon

Hosted by:

09:00-09:30

GERMANY

How the industry is tackling demand outstripping supply and conservatism amongst healthcare professionals.

Linus Maximilian Weber

09:30-10:00

Malta

Hurdles Maltese patients face when accessing medical cannabis.

Andrew Agius

10:00-10:30

United Kingdom

What are the main obstacles facing the UK in the early stages of the legalized medical cannabis industry? main obstacles facing the UK in the early stages of the legalized medical cannabis industry?

Dani Gordon

10:30-11:00

Thailand

Thailand 4.0 initiative, ethical issues and the role of educational institutes.

Suttisak Jantavongso

11:00-11:30

Europe

Human Capital in the emerging medical cannabis industry - Challenges and trends.

Antoaneta Basarbolieva

Thomas Grima

Majrbritt Kristensen

11:30-12:00

Ireland

Ireland, its people and infrastructure; poised and prepared for the hemp and cannabis industries.

Leah Fletcher

12:00-12:30

Africa

Affordability, accessibility and efficacy of cannabinoids and terpenoids for medical conditions.

Kristian Leisegang

12:30-13:00

Ukraine

What obstacles does Ukraine face in the medical cannabis industry and how are organisations working to tackle these?

Vladimir Kapustin

Established Medical Cannabis Markets expand icon

Hosted by:

14:00-14:30

Israel

The importance of Israel as a pioneer in medical cannabis.

Maya Glogowski

Dana Melzer

Keren-or Amar

14:30-15:00

North America

The importance of the Hemp plant going forward in the medical cannabis industry.

Preet Marwaha

15:00-15:30

Jamaica

How the medical cannabis export industry and tourism are helping to create jobs for rural farmers along with other benefits for different parts of the supply chain.
15:30-16:00

Michigan

Scientific Lessons From the Experiences of End-of-Life Cannabis Patients – Cathleen S. Graham, RN CHPN.

Cathleen Graham

16:00-16:30

United States

How is the US leading the way on clinical studies and research into the benefits of medical cannabis?

William J. Pascrell, III

16:30-17:00

Jamaica

Outdoor Cultivation as a Sustainable Business Model.

Markus Hoffmann

Conference Room

Social Impact & Education

Conference Chair

Maya Elisabeth

CEO

Hosted by:

09:00-09:10

Back to the roots: Malta revisits its long tradition in medical innovation

Ladies and gentlemen, please give a warm welcome to the deputy Prime Minister of Malta, the Hon. Chris Fearne, as he shares his thoughts on the medical cannabis sector in Malta.

Hon. Chris Fearne

09:10-09:30

Patient-led industry change

How did Hannah Deacon push for legislative change in the UK and what was the outcome of her persistent efforts?

Hannah Deacon

Michael Barnes

09:30-09:50

Cannabis education: a public approach

What sort of public awareness campaigns are needed to de-stigmatise medical cannabis and give appropriate information on the available options?

Maya Elisabeth

Basia Zieniewicz

Robin  Emerson

William Levine

Moritz Foerster

Julie Moltke

09:50-10:10

Social impact in North America

The social significance of medical cannabis stretches across continents and generations. How might this develop in the near future?

Jim Walsh

Maya Elisabeth

Alix Hadley

Tracy Ryan

10:10-10:30

Psychological well-being: the case for mental health

Managing and treating mental health disorders with medical cannabis isn’t at all unheard of. Let’s discuss the insights for all to hear

Jon Liebling

Mark Braunstein

10:30-10:40

CBD in the UK: a deeper look into the supplements market

How is the the lack of enforcement regarding the supplements market negatively affecting public perception of the cannabinoid industry? What’s to be done on this front?

Stephen Oliver

10:40-11:00

Cannabis use-cases: educating medical professionals

What are the most effective ways of passing on information to medical professionals and practitioners in the health sector?

Michael Miller

Pablo Coirolo

Dani Gordon

Sandra Carrillo

Cathleen Graham

11:00-11:20

The homegrown approach

Let’s look at the case for and against the regulation of private medical cannabis cultivation for chronic pain management.

Carly Barton

Jade Proudman

11:20-11:40

Cause and effect: a psychiatric perspective

Let’s bridge the knowledge gap between the endocannabinoid system and psychiatric-related diseases.

Mauro Maccarrone

11:40-12:00

Marketing the green mile

How do CBD marketing agencies get products into the hands of consumers while abiding by regulatory and payment procedures?

Richard Skaife

Cobichain

Katie Pringle

Lindsay Blackett

Boris Blatnik

12:00-12:20

Battle of the Jurisdictions

In this animated discussion, legal experts from various jurisdictions will go head-to-head in explaining which state is leading the way with regulatory innovation.

Anton John Mifsud

Joe Rogoway

Daniel Torres Gonçalves

Peter Homberg

12:20-12:30

A European harmonisation project?

What initiatives are in place to standardize medical cannabis licensing across Europe?

Gabriel Micallef

12:30-12:40

Enhancing recovery systems for athletes

Medical cannabis can be used to aid in the recovery process while also acting as effective pain relief for injured athletes. Let’s dive in.

Jean-Martin Gauthier

12:40-12:50

Addressing challenges to regulate CBD on a global scale

Social, regulatory and economic hurdles fly in the face of a comprehensive global CBD regulatory framework. Is there a common denominator cross-culturally?

Marija Obradovic

12:50-13:00

Supporting women's health through medical cannabis

It’s time to highlight the importance of advocating for better medical cannabis policies to support women’s reproductive and general health.

Halima Al-Hatimy

13:00-13:20

Treating PTSD with CBD

How is medical cannabis being effectively used for the management of PTSD?

Mark Braunstein

13:20-13:30

Medical cannabis in Malta

Let’s look at the past, present and future of the medical cannabis sector in the small island nation in the heart of the Mediterranean.

Andrew Agius

13:30-13:40

R&D: inspecting the endocannabinoid and central nervous system

Let’s dive into a retrospective analysis on the interplay between human-biological systems.

Laszlo Mechtler

13:40-13:50

The missing link: memory acquisition and emotion

Is the endocannabinoid system an emotional buffer for stressful memories? Let’s find out.

Patrizia Campolongo

13:50-14:00

How safe is medical cannabis?

With all things drug-related, a level-headed and objective risk-benefit analysis is emininently desirable. Fasten your seatbelts for this rapid fire presentation.

Linda Klumpers

Technology & Security

Conference Chair

Monty Munford

Journalist

Forbes

Hosted by:

14:00-14:20

Cross-polination: how blockchain and cannabis are a match made in heaven

How will blockchain disrupt this sector and transform it into a more lucrative and competitive endeavour?

Alex Goodger

Alex Cahana

Felix Mago

Gene Deyev

14:20-14:30

The black market: empowerment through denial?

Pretending to ignore the underground epidemic is just kicking the cannabis can down the road. Let’s hear what an expert-former CIA profiler has to say about that.

Alex Shah

14:30-14:40

From cultivation to waste disposal

How is Malta preparing to address environmental requirements in this growing sector?

Oliver Fenech

14:40-15:10

An honest look at deep tech in a growing market

How are US-driven tech innovations facilitating progress in this fast-paced industyr?

Jacquie Cohen Roth

Michael Patterson

Monica Vialpando

15:10-15:20

Prescriptions, fraud and patient privacy

How do we secure medical records to prevent fraud while maintaining patient privacy in the era of large-scale tech innovations?

Neil Stansbury

15:20-15:30

Medical cannabis: the scientific perspective

What does the science tell us about cannabinoid-based medicine?

Dmytro Isaev

15:30-15:40

Peering across the field: large-scale cultivation and extraction

What are the best practices for the design, build and marketing of cultivation and extraction facilities in Israel, US and Canada?

Adam Shuster

15:40-15:50

Cannabis 2.0

What does the future hold for an emerging cannabis market? Let’s dig in.

Zeid Mohamedali

15:50-16:00

Going global: a regulatory no-brainer

Let’s analyse the case for building a culture of quality and GMP compliance.

Laleh Bighash

16:00-16:10

Addressing the security risk

What can Malta learn about security from international growers?

Yosi Sherman

16:10-16:30

Israel's experience as an establised medical cannabis market

The model for cannabis innovation.

Saul Kaye

16:30-16:40

Next steps: a generational medical shift

How do we develop the next generation of medical and scientifically-backed cannabis technology?

William Levine

16:40-16:50

The Cryptocurrency solution

Cryptocurrency can help lower costs, improve user experience, lower security risks, and increase overall efficiency. Let’s explore how cryptocurrency can alleviate unnecessary risks.

Felix Mago

16:50-17:10

Cannabinoid Therapies and PTSD

This presentation will cover the most recent advances in cannabinoid-based therapies for PTSD patients, including best practices, role of secondary organic compounds such as terpenes, and treatment guidelines.

Francois Hallé

17:10-17:30

Transposition stability to maintain consistency in the cannabinoid market

Jumping genes, also known as transposons are sensitive to even the smallest environmental changes. Let’s take a look at the importance of secondary metabolites to sustain micro-macro environmental stressors.

Srinivasa Reddy

17:30-17:40

Compounds VS. components: amplifying cannabinoids with Terpenes

Time for a brief overview on the boosting effects of aromatic and pharmaceutically active compounds on their isolates.

 

 

Neville Edel

17:40-17:50

Dry powder inhalers

A clean alternative to smoking and vaping

Andreas Boeckl

17:50-18:00

Running a profitable medical cannabis enterprise

How to successfully launch a medical cannabis business and overcome the negative connotations associated with it.

Adam Shuster

Workshop Room

Seed-to-patient Tracking with Blockchain Technology expand icon

Hosted by:

09:00-09:30

How is blockchain technology revolutionising the medical cannabis supply chain?

Petar Savic

Supreme Factory
09:30-10:00

Approaching medical cannabis policies in the context of emerging technologies

Graham De Barra

10:00-10:30

FDA compliance for cannabinoid products.

Dave Rodman

10:30-11:00

Using Cannabis is my business, not yours: Trusted information in a Trustless Environment.

Alex Cahana

11:00-11:30

Solving connectivity in the global hemp trade market

Kenneth Reece

11:30-12:00

Blockchain’s power to transform and improve the cannabis industry.

Pablo Coirolo

12:00-12:30

Utilizing Blockchain and Distributed ledger technology to track regulated Cannabis Sales

Sergio Stephano

Workshop by BDO - Understanding Malta’s Medical Cannabis Proposition expand icon

Hosted by:

09:30-10:00

Tea, Coffee & Networking - BDO stand

10:00-10:20

Welcome & Introduction

Mark Attard

10:20-10:45

Legalising Medical Cannabis

Giannella Barbieri

10:45-11:00

Application Process & Obligations

Luke Attard

11:00-11:30

Income Tax on transactions involving medical cannabis

Josef Mercieca

Milena Palikarova

11:30-11:45

Coffee Break

11:45-12:15

Panel discussion

Mark Attard

BDO

Giannella Barbieri

Josef Mercieca

Mario Galea

Michael Rossi

Yona Levy

Alvit LCS Pharma
12:15-13:00

Pre-lunch networking drinks - BDO stand

Facilitating Taxation & Transparency with Blockchain Technology expand icon

Hosted by:

14:00-14:15

Opportunities and challenges in the Thai Landscape

Veronica Andrino

14:15-14:45

How blockchain solutions can solve the regulatory issues for medical cannabis

Raja Sharif

14:45-15:15

Blockchain and cannabis - Taxes, transparency and self-regulation

Alex Migitko

15:15-15:45

Cryptocurrency for Cannabis: RSU-Arthit Coin

Chetneti Srisa-an

15:45-16:15

Application of Blockchain Technology for Tax Compliance

Antonella Lia

16:45-17:00

Cannabis research & development: understanding the medical use-cases

Jacky Ong

ARE YOU A START-UP?
Fill in the Cannabiz
Start-Up Pitch
application form.
APPLY TODAY!
BECOME A SPEAKER
We’re always looking to collaborate
with thought leaders who are willing to shape the
medical cannabis industry.
SUBMIT
BOOK PASS TODAY!
Grab a ticket!
Low fees for all delegates.
Find out now.
BOOK YOUR PASS!